Gratus Capital’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $2.34M | Buy |
2,109,664
+56,857
| +3% | +$63.1K | 0.09% | 133 |
|
|
2024
Q1 | $2.71M | Buy |
2,052,807
+111,353
| +6% | +$147K | 0.12% | 115 |
|
|
2023
Q4 | $2.91M | Buy |
1,941,454
+254,999
| +15% | +$382K | 0.16% | 102 |
|
|
2023
Q3 | $2.48M | Buy |
1,686,455
+7,662
| +0.5% | +$11.3K | 0.17% | 98 |
|
|
2023
Q2 | $4.21M | Buy |
1,678,793
+23,388
| +1% | +$58.7K | 0.29% | 79 |
|
|
2023
Q1 | $2.47M | Sell |
1,655,405
-12,889
| -0.8% | -$19.2K | 0.19% | 85 |
|
|
2022
Q4 | $2.34M | Buy |
1,668,294
+915,104
| +121% | +$1.28M | 0.19% | 83 |
|
|
2022
Q3 | $2.38M | Buy |
+753,190
| New | +$2.38M | 0.25% | 77 |
|